Topoisomerase 1 and topoisomerase 2 solve the same fundamental problem — tangled, overwound, or underwound DNA — but they do it in mechanically distinct ways. Topoisomerase 1 cuts a single strand of the double helix, while topoisomerase 2 cuts both strands at once. That difference in cutting strategy ripples outward into everything else: how the enzymes are built, what fuel they need, which cellular jobs they handle, and which drugs target them.
One Strand Versus Two
Every time a cell copies or reads its DNA, the double helix has to unwind. That unwinding creates tension — imagine holding a twisted phone cord at both ends and pulling it apart in the middle. The twists pile up ahead of and behind the opening point. Topoisomerases exist to relieve that tension, but they take fundamentally different approaches.
Topoisomerase 1 (Top1) works as a single protein unit. It nicks one strand of the DNA, holds onto the cut end, lets the intact strand rotate to release tension, and then reseals the break. The enzyme attaches itself to the 3′ end of the broken strand through a direct chemical bond. Crucially, it does all of this without consuming any energy — no ATP required.1SpringerLink. Topoisomerase I and II Activity Assays
Topoisomerase 2 (Top2), by contrast, works as a pair — two identical protein subunits joined together. It cuts both strands of the helix simultaneously, creating a temporary double-strand break with a four-base-pair overhang. The enzyme grabs the 5′ ends of the cut (the opposite ends from where Top1 attaches), passes another segment of DNA through the gap, and then reseals both strands. This process burns ATP.1SpringerLink. Topoisomerase I and II Activity Assays
The ATP requirement makes sense when you consider what Top2 is doing. Passing one DNA segment through another is active work — the enzyme has to open a gate, thread the DNA through, and close the gate behind it. Experiments with a nonhydrolyzable ATP analog (a molecule that looks like ATP but can’t be broken down) showed that Top2 operates through a “two-gate” model: DNA enters through one gate and exits through another on the opposite side of the enzyme, and the entrance gate locks shut irreversibly once ATP binds.2PubMed. DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism
Subfamilies and Why They Matter
Calling them “type 1” and “type 2” makes it sound like there are just two enzymes, but each type actually contains subfamilies with different structures and mechanisms. Type I topoisomerases split into at least two major groups: type IA and type IB. Type IA enzymes (like bacterial topoisomerase I and topoisomerase III in both bacteria and human cells) attach to the 5′ end of the broken strand and work by passing an intact strand through the gap. Type IB enzymes (including human Top1, the one most people mean when they say “topoisomerase 1”) attach to the 3′ end and use the controlled-rotation mechanism described above.3PubMed Central. Type IA DNA topoisomerases: strictly one step at a time
On the type II side, human cells produce two isoforms: topoisomerase IIα and topoisomerase IIβ. They share the same basic double-strand-break-and-pass mechanism, but they serve strikingly different purposes. Top2α is essential for cell division — without it, cells cannot proliferate. Top2β, on the other hand, is dispensable for dividing cells but plays a specialized role in nerve growth and brain development.4PubMed Central. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo
The human genome encodes six topoisomerase enzymes in total, spanning both families.5PubMed. Emerging roles of DNA topoisomerases in the regulation of R-loops These aren’t just slight variations of each other. Analysis of their evolutionary histories shows that the main topoisomerase families — type IA, type IB, type IIA, and type IIB — are not related by common ancestry. They appear to have evolved independently, converging on the same general solution (cutting DNA to relieve tension) from entirely different starting points.6PubMed. Origin and evolution of DNA topoisomerases
Different Jobs in the Same Cell
Although Top1 and Top2 both relax DNA tension, they tend to handle different flavors of that tension. When a gene is being read, the machinery that slides along the DNA creates positive supercoiling ahead of it (the DNA winds tighter) and negative supercoiling behind it (the DNA unwinds too much). Studies in yeast ribosomal RNA genes showed a clean division of labor: Top2 primarily resolves the positive supercoiling that builds up in front of the advancing machinery, while Top1 handles the negative supercoiling that forms behind it.7PubMed Central. Distinguishing the roles of Topoisomerases I and II in relief of transcription-induced torsional stress in yeast rRNA genes
Top2 also has a job that Top1 simply cannot do: separating tangled chromosomes. After a cell copies all of its DNA in preparation for dividing, the two resulting copies of each chromosome are often physically interlinked, like chain links hooked through each other. These tangles are called catenanes, and because they involve two separate double-stranded DNA molecules looped around one another, only an enzyme that cuts both strands can unlink them. Top2 completely removes this intertwining between sister chromosomes before the cell pulls them apart during division.8PubMed. Positive supercoiling of mitotic DNA drives decatenation by topoisomerase II in eukaryotes If Top2 fails at this task, chromosomes can’t separate properly, and the cell is in serious trouble.
This decatenation job is so important that other cellular machinery actively assists it. Condensin, a protein complex that helps compact chromosomes, works alongside Top2 to ensure the tangled DNA gets properly unlinked before chromosome separation.9PubMed Central. Condensin aids sister chromatid decatenation by topoisomerase II
How Fast Do They Work
Single-molecule experiments — setups where researchers literally watch one enzyme process one pair of DNA molecules in real time — have given a concrete sense of Top2’s speed. By mechanically braiding two DNA molecules together and then adding purified enzyme, researchers measured Drosophila (fruit fly) Top2 relaxing these braids at a rate of roughly 2.9 strand passages per second. The bacterial equivalent, topoisomerase IV, worked at about 2.4 per second but showed a strong preference for left-handed braids, which it relaxed completely and processively, while Top2 handled both left- and right-handed braids similarly.10PubMed Central. Single-molecule study of DNA unlinking by eukaryotic and prokaryotic type-II topoisomerases
That handedness preference in bacterial topoisomerase IV is functionally meaningful. In bacteria, the chromosome is circular and the tangles produced during replication tend to have a specific geometry. An enzyme tuned to prefer that geometry can work more efficiently at separating newly copied chromosomes.
Cancer Drugs That Target Each Type
The fact that topoisomerases make temporary breaks in DNA creates a therapeutic opportunity: if you can trap the enzyme on the DNA while the break is still open, that temporary nick becomes a permanent, lethal lesion. This is the basic strategy behind several major classes of cancer drugs.
Drugs targeting Top1 are modeled on camptothecin, a natural compound originally isolated from a Chinese tree. Camptothecin-based drugs (irinotecan and topotecan are the most widely used) work by wedging themselves into the interface between Top1 and the DNA it has nicked. They don’t inhibit the enzyme outright — they stabilize the normally fleeting enzyme-DNA complex, preventing the break from being resealed.11PubMed. Topoisomerase I inhibitors: camptothecins and beyond When the cell’s replication or transcription machinery crashes into this trapped complex, the single-strand nick converts into a catastrophic break.
Drugs targeting Top2 fall into two categories with very different mechanisms. “Poisons” like etoposide and doxorubicin prevent the enzyme from resealing the double-strand break it has created, locking the DNA in a cut state. “Catalytic inhibitors” work at different stages of the enzyme’s cycle — some block Top2 from binding DNA in the first place, and others, like the bisdioxopiperazine family, lock the enzyme into a closed ring around the DNA after it has already resealed the break, preventing it from starting a new catalytic cycle.12PubMed. Mapping of DNA topoisomerase II poisons and catalytic inhibitors to four distinct steps in the topoisomerase II catalytic cycle
The poison-versus-inhibitor distinction matters clinically. A catalytic inhibitor can actually antagonize a poison if given at the same time, because if Top2 never binds DNA or never creates a break, there’s nothing for the poison to trap. Understanding where each drug acts in the catalytic cycle helps oncologists avoid self-defeating combinations.
Why Doxorubicin Hurts the Heart
One of the most clinically significant differences between the two Top2 isoforms shows up in cardiotoxicity. Doxorubicin, among the most effective and widely used cancer drugs, targets Top2 — but it does not distinguish between Top2α (the one driving tumor cell division) and Top2β (the one involved in nerve and brain development, also expressed in heart muscle cells). This lack of selectivity is the root of a serious side effect: progressive heart failure in some patients.
Research showed that deleting the gene for Top2β specifically in heart muscle cells protected mice from doxorubicin-induced heart failure. Without Top2β in cardiomyocytes, doxorubicin could not generate the double-strand DNA breaks that trigger downstream damage — specifically, disrupted mitochondrial function and the buildup of destructive reactive oxygen species.13PubMed. Identification of the molecular basis of doxorubicin-induced cardiotoxicity Earlier work had already implicated Top2β in this process, showing that the proteasome (the cell’s protein-disposal machinery) breaks down the trapped Top2β-DNA complex, exposing the hidden double-strand breaks beneath it.14PubMed. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
Dexrazoxane, a drug sometimes given alongside doxorubicin to protect the heart, appears to work at least in part by interfering with Top2β before the damage occurs. This fits with its known mechanism as a bisdioxopiperazine — the same class of catalytic inhibitors that locks Top2 in its closed-ring form. By preventing Top2β from creating breaks in cardiomyocyte DNA, dexrazoxane short-circuits the entire damage cascade.14PubMed. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
When Trapped Enzymes Become Toxic Lesions
Whether trapped by a drug or by an accidental malfunction, a topoisomerase stuck on DNA with an open break is a serious problem. The cell has dedicated repair enzymes to deal with exactly this scenario. Two enzymes called TDP1 and TDP2 (tyrosyl-DNA phosphodiesterases) were discovered specifically because they clip the chemical bond between a stuck topoisomerase and the DNA end it’s attached to. TDP1 handles the 3′ attachments left by trapped Top1, while TDP2 handles the 5′ attachments left by trapped Top2 — matching the polarity of each enzyme’s cut.15PubMed Central. Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2)
These repair enzymes also process other types of DNA damage beyond topoisomerase-related lesions, but their primary claim to fame remains clearing trapped topoisomerase complexes. When a topoisomerase becomes covalently stuck on DNA (forming what researchers call a “cleavage complex”), the resulting lesion threatens cell survival by blocking replication and transcription and, if left unresolved, can trigger chromosome breaks and cell death.16PubMed. Post-Translational Modifications Orchestrate Repair of Trapped Topoisomerase-Induced DNA Breaks via TDP1 and TDP2
The existence of TDP1 and TDP2 has practical consequences for cancer treatment. Cancer cells that overexpress these repair enzymes can more efficiently clear trapped topoisomerase complexes, potentially making them resistant to topoisomerase-targeting drugs. Resistance to these drugs in breast cancer, for instance, often involves both reduced expression of the target enzyme (so there’s less to trap) and enhanced DNA repair capacity (so trapped complexes get fixed faster).17Drug Targets and Therapeutics. Topoisomerase Inhibitor Resistance in Breast Cancer: Exploring Alterations in Cellular Metabolism and Properties Driving Drug Insensitivity
R-Loops and Genome Stability
Beyond classical supercoiling, topoisomerases are increasingly recognized for their involvement in managing R-loops — hybrid structures where a freshly made RNA strand pairs with one of the two DNA strands, leaving the other DNA strand hanging as a single strand. R-loops form naturally during transcription and have regulatory functions, but when they persist or accumulate in the wrong places, they threaten genome stability by stalling replication forks and triggering DNA damage. Topoisomerases, by relaxing the supercoiling that promotes R-loop formation, help keep these structures in check.5PubMed. Emerging roles of DNA topoisomerases in the regulation of R-loops
This is an area where the interplay between Top1 and Top2 gets complicated. Negative supercoiling behind a transcribing complex tends to favor R-loop formation because underwound DNA is easier for RNA to invade. Since Top1 is the primary resolver of negative supercoiling behind active genes, losing Top1 function can lead to R-loop accumulation and the genome instability that follows. Top2 contributes more indirectly by managing the positive supercoiling ahead of transcription, but both enzymes factor into the overall topological landscape that determines whether R-loops form or resolve.
Bacterial Topoisomerases and Antibiotics
Bacteria have their own type II topoisomerases — DNA gyrase and topoisomerase IV — and these differ enough from the human versions to serve as drug targets. Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin, and others) work by trapping bacterial gyrase and topoisomerase IV on DNA, in much the same way that etoposide traps human Top2. Two drug molecules wedge into the DNA at the sites where the enzyme has made its cuts, forming a stabilized drug-enzyme-DNA complex through interactions that involve a magnesium ion bridge between the drug and specific amino acids in the enzyme subunits.18Oxford Academic. Bacterial DNA topoisomerase IV and DNA gyrase inhibitors: history of the quinolones, their clinical usage and potential alternatives for the future
The structural differences between bacterial and human type II topoisomerases are what make fluoroquinolones effective antibiotics rather than indiscriminate cell poisons. Gyrase, in particular, has no direct human equivalent — it is the only topoisomerase that can actively introduce negative supercoils into DNA (rather than just removing excess supercoiling), a function bacteria need to keep their circular chromosomes compact and accessible. Human Top2 can relax supercoils but cannot wind DNA up from scratch in the same way.
A Topoisomerase Just for Mitochondria
Mitochondria, the cell’s energy-producing compartments, carry their own small circular DNA genomes. These genomes face the same topological problems that nuclear DNA does — copying and reading them creates supercoiling tension that needs to be resolved. Cells have a dedicated enzyme for this: mitochondrial topoisomerase I (Top1MT), which exists exclusively inside mitochondria and is critical for mitochondrial DNA metabolism. It relieves the topological stress created during mitochondrial DNA replication and transcription, and its activity is essential for mitochondrial DNA expansion during tissue regeneration.19PubMed Central. Mitochondrial topoisomerase I (Top1MT) prevents the onset of metabolic dysfunction-associated steatohepatitis (MASH) in mice
Top1MT is a type IB enzyme, mechanistically similar to nuclear Top1, but its exclusive mitochondrial localization means it never participates in nuclear DNA management. Interestingly, loss of Top1MT in mice doesn’t cause immediate catastrophe but instead produces subtler metabolic problems — the enzyme appears to be especially important during periods of high mitochondrial demand, such as liver regeneration. This compartmentalized arrangement underscores how cells have parceled out topoisomerase duties not just by enzyme type but by physical location within the cell.
Why Independently Evolved Enzymes All Converge on the Same Trick
Perhaps the most remarkable aspect of the topoisomerase story is that these enzyme families are not descended from a common ancestor. Type IA, type IB, type IIA, and type IIB topoisomerases all appear to have originated independently over evolutionary time.6PubMed. Origin and evolution of DNA topoisomerases The fact that nature invented the “cut, rearrange, and reseal” strategy for DNA management multiple separate times speaks to how unavoidable the topological problem is. Any organism that stores genetic information in a double-stranded helix and needs to copy or read it will eventually run into supercoiling. The math of twisted polymers guarantees it.
Different domains of life have assembled different toolkits from these families. Bacteria rely heavily on gyrase (type IIA) for introducing negative supercoils and topoisomerase IV (also type IIA) for chromosome segregation. Archaea often use a type IIB enzyme (topoisomerase VI) that has no close counterpart in bacteria or humans. Eukaryotes lean on type IB (Top1) for transcription-associated relaxation and type IIA (Top2α and Top2β) for replication, chromosome segregation, and specialized developmental roles. The toolkit varies, but the underlying need — managing the geometry of the double helix — is universal.